---------
If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!
Added September 13th, 2005
Following intense criticism over inappropriate, glossy advertising for drugs, Pfizer, the pharmaceutical giant that manufactures drugs such as Bextra, has pledged that it will not be directly advertising new products to consumers for at least six months. Pfizer, and other drugs companies such as Merck, have come under fire by critics recently for their stance on glossy advertising with regards to potentially dangerous drugs.
The pharmaceutical industry has recently announced new guidelines with regards to the communication of drug risks and benefits to consumers. It is hoped that the new regulations and guidelines will improve the way such information is portrayed and passed on to consumers, hence aiding the safety and the responsible administration of these drugs.
Federal regulators have already asked drug companies such as Merck and Pfizer to advertise more appropriately, or in some cases to stop advertising certain drugs altogether. Over four billion dollars was spent on drug advertising by the pharmaceutical industry in 2004 alone, and critics state that this type of advertising has exploded in recent years.
Although these new guidelines have been introduced by the pharmaceutical industry, there is no penalty for failure to adhere to them, and it is therefore possible that some pharmaceutical companies may ignore them altogether.
Pfizer To Cut Back On... | Printable Version (Opens In New Window)